University Hospital, Bordeaux: Neoplasms trials

The registry lists 13 Neoplasms studies with University Hospital, Bordeaux as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile BiopsyRecruitingNCT06416397
• Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)RecruitingNCT05839717
• Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver MetastasesRecruitingNCT04837885Phase 2
• Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With CancerCompletedNCT06444477
• Evaluation of New Biomarkers of Thrombosis in Myeloproliferative NeoplasmsCompletedNCT04177576
• Practices and Organizations Related to Emerging Occupations of Care (EPOCK) Coordination in OncologyCompletedNCT03350776
• Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative NeoplasmsCompletedNCT02823184
• Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric TumorsCompletedNCT02334930
• Assessment of in Vivo Skeletal Muscle Viscoelasticity (ARFI Imaging) With Aging and CancerCompletedNCT01484821Not applicable
• Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized StudyCompletedNCT01432067Not applicable
• Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
• Evaluation of [18F]-FMISO for Non Operated GlioblastomaCompletedNCT00906893Phase 2
• Thyroid Cancer and SunitinibCompletedNCT00510640Phase 2